Rivaroxaban Prophylaxis Dose
For VTE prophylaxis in adult patients without severe renal impairment, rivaroxaban 10 mg once daily is the standard prophylactic dose.
Dosing by Clinical Indication
Orthopedic Surgery Prophylaxis
- Hip replacement surgery: 10 mg once daily for 35 days, starting 6-10 hours post-surgery once hemostasis is established 1, 2
- Knee replacement surgery: 10 mg once daily for 12 days, starting 6-10 hours post-surgery once hemostasis is established 1, 2
- Can be taken with or without food 2
Acutely Ill Medical Patients
- Standard dose: 10 mg once daily for 31-39 days total (in-hospital plus post-discharge) 2
- This applies to patients at risk for thromboembolic complications with moderate/severe restricted mobility who are not at high risk of bleeding 2
Renal Function Considerations
The prophylactic dose remains 10 mg once daily across most renal function levels, but monitoring requirements differ:
- CrCl ≥50 mL/min: No dose adjustment needed 3, 2
- CrCl 30-50 mL/min (moderate impairment): 10 mg once daily is appropriate, but use with caution and monitor closely for bleeding 3, 2
- CrCl 15-30 mL/min (severe impairment): 10 mg once daily produces similar drug exposure to moderate impairment; observe closely for bleeding signs 2, 4
- CrCl <15 mL/min: Avoid use 2
Important Renal Dosing Nuances
The evidence shows that rivaroxaban exposure plateaus in moderate and severe renal impairment, with comparable drug levels between CrCl 30-50 mL/min and CrCl 15-30 mL/min 4. This pharmacokinetic profile supports maintaining the 10 mg prophylactic dose even in severe impairment, though clinical trial data excluded patients with CrCl <30 mL/min 2.
Key Clinical Caveats
Contraindications for prophylactic use:
- Severe renal impairment (CrCl <30 mL/min) per manufacturer labeling, though FDA guidance suggests 10 mg may be used with close monitoring down to CrCl 15 mL/min 2
- Moderate to severe hepatic impairment (Child-Pugh B or C) 2
- Any hepatic disease with coagulopathy 2
Special populations requiring caution:
- Elderly patients (>75 years) with moderate renal impairment 3
- Patients on P-glycoprotein inhibitors or CYP3A4 inhibitors 5
- Patients weighing <50 kg 3
Timing and Administration
- Post-surgical initiation: Start 6-10 hours after surgery once hemostasis is established 1, 2
- Medical patients: Can initiate immediately upon hospitalization 2
- Food requirements: Prophylactic doses (10 mg) can be taken with or without food, unlike higher therapeutic doses 2
Common Pitfalls to Avoid
Do not confuse prophylactic with therapeutic dosing: Treatment doses for acute VTE are 15 mg twice daily for 3 weeks, then 20 mg once daily 1, 6—substantially higher than prophylactic dosing
Do not automatically reduce dose in moderate renal impairment: The 10 mg prophylactic dose is maintained even with CrCl 30-50 mL/min, unlike some other indications where dose reduction occurs 2
Avoid bridging with heparin: There is no need for preoperative or concurrent heparin bridging when using rivaroxaban for prophylaxis 5
Do not use PT/INR for monitoring: Standard coagulation tests are unreliable for assessing rivaroxaban effect due to variable reagent sensitivity 1